The original printing is just one of 26 known remaining copies, and one of three located west of the Appalachian Mountains.

Novartis AG’s exit from its listed Indian subsidiary highlights a growing trend of "Big Pharma" companies divesting from the hyper-competitive Indian market.

GLP-1 QUESTIONS — Drug pricing deals struck with the makers of blockbuster weight loss drugs last November were hailed by President Donald Trump as a game changer for Americans seeking more affordable ...

Religious private schools and families sign up for Texas Education Savings Account program.

Interest in the use and impacts of glucagon-like peptide-1 receptor agonists in rheumatology has exploded over the past year, a trend that appeared to crescendo at ACR Convergence 2025. There, ...

Thanks to high-concept stories with significant production costs and complex logistics, sci-fi shows are often on the ...

For Mónica Ramírez, being named one of this year’s 10 Elevate Prize winners means so much more than the monetary and structural support that comes with it.

Gene-editing approaches being developed by two companies show hints that switching off certain genes could dramatically ...

O’Neal speaks with Sports Illustrated's Greg Cally at the Milan Cortina 2026 Winter Olympics to talk Team USA pride as a former Olympian, the state of the NBA Dunk Contest, and launching a new athlete ...

Wall Street is overly focused on GLP-1 drugs even as this medical device maker continues to thrive.

The glucagon-like peptide 1 (GLP-1) market is poised for growth due to rising diabetes and obesity rates, expanded therapy options, and a focus on personalized medicine. Innovations in oral GLP-1 ...